- 专利标题: MODULATING T CELL FUNCTION AND RESPONSE
-
申请号: US16936874申请日: 2020-07-23
-
公开(公告)号: US20210024890A1公开(公告)日: 2021-01-28
- 发明人: Chengfei Pu , Wensheng Wang , Dongqi Chen , Lei Xiao
- 申请人: Innovative Cellular Therapeutics Holdings, Ltd. , Innovative Cellular Therapeutics, Inc.
- 申请人地址: KY Grand Cayman; US MD Rockville
- 专利权人: Innovative Cellular Therapeutics Holdings, Ltd.,Innovative Cellular Therapeutics, Inc.
- 当前专利权人: Innovative Cellular Therapeutics Holdings, Ltd.,Innovative Cellular Therapeutics, Inc.
- 当前专利权人地址: KY Grand Cayman; US MD Rockville
- 主分类号: C12N5/0783
- IPC分类号: C12N5/0783 ; C07K14/705 ; C07K16/28 ; C07K14/725
摘要:
The present disclosure describes a method of producing T cells exhibiting an enhanced memory T cell phenotype, the method comprising: modulating a population of T cells to enhance the expression and/or function of high mobility group protein Y (HMGY). In embodiments, the method may include introducing a polynucleotide encoding HMGY into a population of T cells, wherein expression of HMGY is higher in the population of T cells as compared to a population of T cells that are not introduced with the polynucleotide, and the memory T cell phenotype of the population of T cells is enhanced as compared to T cells that are not introduced with the polynucleotide. In embodiments, the method can also include introducing a polynucleotide encoding one or more genes associated with HMGY, for example, upstream or downstream of the signaling pathway associated with HMGY and/or a transcription factor associated with HMGY.
信息查询